Evaluation of SAR408701 in Patients With Advanced Solid Tumors
NCT02187848
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
254
Enrollment
INDUSTRY
Sponsor class
Stopped
Sponsor decision, The decision is not related to any safety concern.
Conditions
Neoplasm Malignant
Interventions
DRUG:
SAR408701
Sponsor
Sanofi